当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 现金流量表

康美药业

(600518)

  

流通市值:214.25亿  总市值:214.35亿
流通股本:138.22亿   总股本:138.29亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,100,733,187.995,487,861,781.144,001,236,403.642,421,203,920.09
  收到其他与经营活动有关的现金16,643,475.2495,413,442.6778,876,328.1267,021,985.42
  经营活动现金流入小计1,117,376,663.235,583,275,223.814,080,112,731.762,488,225,905.51
  购买商品、接受劳务支付的现金868,846,629.964,211,733,743.293,016,632,529.21,947,835,816.38
  支付给职工以及为职工支付的现金195,260,163.38752,389,109.84557,655,764.08372,580,697.57
  支付的各项税费25,998,607.56155,538,840.35103,929,261.4371,964,361.86
  支付其他与经营活动有关的现金82,026,611.59352,266,902.46264,052,677.25177,961,877.38
  经营活动现金流出小计1,172,132,012.495,471,928,595.943,942,270,231.962,570,342,753.19
  经营活动产生的现金流量净额-54,755,349.26111,346,627.87137,842,499.8-82,116,847.68
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额2,149,941.539,788,889.3220,080,726.328,258,543.38
  收到的其他与投资活动有关的现金1---
  投资活动现金流入小计2,149,942.539,788,889.3220,080,726.328,258,543.38
  购建固定资产、无形资产和其他长期资产支付的现金15,701,885.89217,059,298.3874,116,991.925,543,694.54
  投资活动现金流出小计15,701,885.89217,059,298.3874,116,991.925,543,694.54
  投资活动产生的现金流量净额-13,551,943.39-177,270,409.06-54,036,265.58-17,285,151.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,800,0001,400,000500,000
  其中:子公司吸收少数股东投资收到的现金-1,800,0001,400,000500,000
  取得借款收到的现金1,000,000---
  收到其他与筹资活动有关的现金41,312,265.95375,520,528.09187,093,185.9972,933,804.21
  筹资活动现金流入小计42,312,265.95377,320,528.09188,493,185.9973,433,804.21
  偿还债务支付的现金-43,500,00043,500,000-
  分配股利、利润或偿付利息支付的现金250,000295,878.445,878.445,878.4
  其中:子公司支付给少数股东的股利、利润250,000295,878.445,878.445,878.4
  支付其他与筹资活动有关的现金8,337,100.344,274,406.5427,282,963.2418,855,107.87
  筹资活动现金流出小计8,587,100.388,070,284.9470,828,841.6418,900,986.27
  筹资活动产生的现金流量净额33,725,165.65289,250,243.15117,664,344.3554,532,817.94
四、汇率变动对现金及现金等价物的影响-16,599.73-13,988.28-6,353.221,732.58
五、现金及现金等价物净增加额-34,598,726.73223,312,473.68201,464,225.35-44,867,448.32
  加:期初现金及现金等价物余额1,066,292,345.45842,979,871.77842,979,871.77842,979,871.77
  期末现金及现金等价物余额1,031,693,618.721,066,292,345.451,044,444,097.12798,112,423.45
补充资料:
  净利润-12,429,169.97-18,315,653.88
  资产减值准备-184,382,843.48-798,690.5
  固定资产和投资性房地产折旧-255,874,663.21-130,325,915.11
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-255,874,663.21-130,325,915.11
  无形资产摊销-21,880,963.63-8,930,044.4
  长期待摊费用摊销-21,053,236.84-10,241,512.7
  处置固定资产、无形资产和其他长期资产的损失--846,811.6--286,015.92
  固定资产报废损失-1,464,525.08-686,507.3
  公允价值变动损失--6,681.98-919.26
  财务费用-18,388,961.03-3,762,182.6
  投资损失--90,603,779.48--231,879.41
  递延所得税-2,637,517.69-1,250,650.31
  其中:递延所得税资产减少-10,189,631.01-4,127,412.28
    递延所得税负债增加--7,552,113.32--2,876,761.97
  存货的减少-96,050,179.07-69,178,861.68
  经营性应收项目的减少--128,258,484.48--153,489,458.71
  经营性应付项目的增加--290,337,008.43--146,396,862.81
  现金的期末余额-1,066,292,345.45-798,112,423.45
  减:现金的期初余额-842,979,871.77-842,979,871.77
  现金及现金等价物的净增加额-223,312,473.68--44,867,448.32
公告日期2026-04-302026-04-182025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑